These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


266 related items for PubMed ID: 26134257

  • 1. Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study.
    Møller E, Pedersen SA, Vinicoff PG, Bardow A, Lykkeaa J, Svendsen P, Bakke M.
    Toxins (Basel); 2015 Jun 30; 7(7):2481-93. PubMed ID: 26134257
    [Abstract] [Full Text] [Related]

  • 2. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
    Suskind DL, Tilton A.
    Laryngoscope; 2002 Jan 30; 112(1):73-81. PubMed ID: 11802042
    [Abstract] [Full Text] [Related]

  • 3. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ, Glasson C, O'Flaherty SJ.
    Dev Med Child Neurol; 2006 Nov 30; 48(11):883-7. PubMed ID: 17044954
    [Abstract] [Full Text] [Related]

  • 4. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S.
    Am J Phys Med Rehabil; 2017 Feb 30; 96(2):68-76. PubMed ID: 28099276
    [Abstract] [Full Text] [Related]

  • 5. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N, Penn C.
    Int J Lang Commun Disord; 2011 Feb 30; 46(5):550-63. PubMed ID: 21899672
    [Abstract] [Full Text] [Related]

  • 6. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
    Savarese R, Diamond M, Elovic E, Millis SR.
    Am J Phys Med Rehabil; 2004 Apr 30; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
    Wilken B, Aslami B, Backes H.
    Neuropediatrics; 2008 Aug 30; 39(4):200-4. PubMed ID: 19165707
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series.
    Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hulst K, Gabreëls FJ.
    Eur J Pediatr; 2001 Aug 30; 160(8):509-12. PubMed ID: 11548191
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.
    Int J Pediatr Otorhinolaryngol; 2016 Sep 30; 88():142-5. PubMed ID: 27497402
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review.
    Calim OF, Hassouna HNH, Yildirim YS, Dogan R, Ozturan O.
    Ann Otol Rhinol Laryngol; 2019 Feb 30; 128(2):104-112. PubMed ID: 30371109
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.